ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through

Sarah Theresa Boyle1, Valentina Poltavets1, Jasreen Kular1

  • 1Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.

Nature Cell Biology
|May 27, 2020
PubMed

Insights

Breast cancer growth is fueled by a pathway involving Rho-associated kinase (ROCK) and protein-kinase-R-like endoplasmic reticulum kinase (PERK). This axis educates cancer-associated fibroblasts (CAFs), promoting tumor progression and offering new therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Microenvironment Research

Background:

  • Cancers extensively utilize their microenvironment to facilitate tumor growth.
  • The precise molecular mechanisms governing cancer-microenvironment interactions remain incompletely understood.
  • Identifying these mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which mammary tumor epithelium interacts with and educates cancer-associated fibroblasts (CAFs).
  • To identify key signaling pathways and factors involved in cancer-microenvironment crosstalk.
  • To explore the therapeutic potential of targeting identified pathways in breast cancer.

Main Methods:

  • Investigated the role of Rho-associated kinase (ROCK) in mammary tumor cells.
  • Analyzed the activation of protein-kinase-R-like endoplasmic reticulum kinase (PERK) downstream of ROCK.
  • Identified cysteine-rich with EGF-like domains 2 (CRELD2) as a key paracrine factor using patient and mouse tumor samples.
  • Examined the regulation of CRELD2 by ATF4 and the impact of CRELD2 depletion on tumor progression.

Main Results:

  • ROCK in the mammary tumor epithelium activates PERK.
  • Activated PERK leads to the recruitment and education of tumor-promoting CAFs.
  • CRELD2 is identified as the paracrine mediator of PERK-driven CAF education.
  • The ROCK-PERK-ATF4-CRELD2 signaling axis was found to drive breast cancer progression.

Conclusions:

  • The paracrine axis involving ROCK, PERK, ATF4, and CRELD2 plays a significant role in promoting breast cancer progression.
  • Targeting this axis could represent a novel therapeutic strategy for breast cancer.
  • Understanding these molecular interactions is vital for advancing cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K